Related Experiment Video
Updated: Oct 20, 2025

06:07
Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease
Published on: June 23, 2023
1.8K
Retromer dependent changes in cellular homeostasis and Parkinson's disease
Zhe Yang1, Zebin Li1, Rohan D Teasdale1
1School of Biomedical Sciences, Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.
Essays in Biochemistry
|September 16, 2021
Summary
Parkinson's disease treatments are limited because its cause is unclear. This review explores how retromer gene variants disrupt cellular trafficking, potentially driving Parkinson's disease progression.
Area of Science:
- Neuroscience
- Cell Biology
- Genetics
Background:
- Parkinson's disease (PD) lacks mechanistic treatments due to unclear underlying causes.
- Endosomes and cellular homeostasis are increasingly implicated in PD pathophysiology.
- Retromer complex variants are identified in familial PD patients.
Purpose of the Study:
- To review the role of retromer complex in Parkinson's disease.
- To summarize how PD-associated retromer variants disrupt cellular trafficking.
- To explore retromer interactions with other PD-associated genes.
Main Methods:
- Literature review of current research on retromer complex and Parkinson's disease.
- Analysis of studies on endosomal trafficking and cellular homeostasis in PD.
- Examination of genetic variants within the retromer complex in familial PD.
Main Results:
- Retromer variants disrupt the cargo sorting function of the endosomal system.
- Disrupted trafficking by retromer contributes to cellular dysfunction in PD.
- Retromer interacts with other PD-associated genes, influencing disease progression.
Conclusions:
- The retromer complex is a critical player in PD pathogenesis.
- Understanding retromer's role in cellular trafficking offers potential therapeutic targets for PD.
- Further research into retromer-gene interactions may elucidate PD mechanisms.
Related Concept Videos
Parkinson's Disease: Overview
854
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
854
Parkinson's Disease: Treatment
447
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
447
Neural Regulation
40.6K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
40.6K
Lysosomal Hydrolases
4.0K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.0K

